Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.36B | 3.17B | 2.83B | 2.96B | 2.19B | Gross Profit |
1.80B | 1.70B | 1.38B | 1.55B | 1.09B | EBIT |
536.97M | 538.69M | 306.09M | 493.87M | 282.76M | EBITDA |
719.12M | 696.64M | 464.09M | 627.01M | 295.21M | Net Income Common Stockholders |
408.00M | 404.10M | 220.46M | 360.82M | 107.76M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
816.83M | 697.69M | 447.72M | 638.00M | 702.65M | Total Assets |
4.07B | 3.95B | 3.54B | 3.66B | 3.67B | Total Debt |
924.22M | 852.20M | 788.19M | 833.09M | 1.03B | Net Debt |
107.39M | 154.51M | 343.81M | 199.93M | 322.49M | Total Liabilities |
1.35B | 1.31B | 1.21B | 1.30B | 1.41B | Stockholders Equity |
2.72B | 2.63B | 2.32B | 2.35B | 2.25B |
Cash Flow | Free Cash Flow | |||
367.69M | 416.04M | 53.36M | 369.27M | 303.87M | Operating Cash Flow |
521.19M | 575.76M | 238.72M | 510.72M | 376.32M | Investing Cash Flow |
-145.47M | -154.96M | -227.55M | -140.83M | -47.32M | Financing Cash Flow |
-227.70M | -173.64M | -184.09M | -439.50M | -32.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $27.90B | 12.27 | 8.95% | 4.36% | -3.09% | 0.67% | |
75 Outperform | HK$1.34B | 4.15 | 6.05% | ― | 13.36% | ― | |
74 Outperform | HK$4.00B | 9.87 | 15.04% | 4.32% | 6.05% | 1.32% | |
69 Neutral | HK$303.80M | 4.33 | 12.35% | 7.31% | 11.56% | 20.29% | |
65 Neutral | $69.65B | 15.08 | 6.22% | 1.71% | -2.82% | 11.93% | |
54 Neutral | $5.41B | 3.27 | -45.10% | 3.29% | 16.81% | 0.02% |
Modern Dental Group Limited reported a 5.3% increase in revenue for the first quarter of 2025, driven by strategic acquisitions and digital transformation efforts. Despite challenges in certain markets, the company has successfully leveraged global digitalization trends to enhance its competitiveness and market share, particularly through the acquisition of Hexa Ceram and a focus on mid- to high-value customers.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.
Modern Dental Group Limited held its annual general meeting on May 29, 2025, where all proposed resolutions were approved by shareholders. Key resolutions included the approval of the audited financial statements for 2024, the declaration of a final dividend, the re-election of directors, and the re-appointment of Ernst & Young as auditors. The meeting also granted the board general mandates to buy back shares and issue additional shares, reflecting shareholder confidence in the company’s strategic direction.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.
Modern Dental Group Limited has announced the appointment of Ms. Chan Yik Yu as a member of its nomination committee, effective from May 29, 2025. This strategic appointment is expected to enhance the company’s governance structure, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.
Modern Dental Group Limited has announced the composition of its board of directors and the roles and functions of each member. This announcement highlights the company’s commitment to strong corporate governance and strategic leadership, which may impact its operational efficiency and market positioning positively.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.
Modern Dental Group Limited has updated the terms of reference for its Nomination Committee, initially adopted in 2015 and previously updated in 2018. The committee is tasked with ensuring a fair and transparent process for board appointments, identifying suitable candidates, and making recommendations to the board and shareholders. This update underscores the company’s commitment to robust governance practices, potentially enhancing its industry positioning and stakeholder trust.
The most recent analyst rating on (HK:3600) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on Modern Dental Group Limited stock, see the HK:3600 Stock Forecast page.
Modern Dental Group Limited has announced its upcoming annual general meeting scheduled for May 29, 2025, where key resolutions will be discussed. These include the approval of financial statements, declaration of a final dividend, re-election of directors, re-appointment of auditors, and granting mandates for share buybacks and issuance. These resolutions, if passed, will allow the company to manage its capital structure effectively and ensure continued governance and operational efficiency.
Modern Dental Group Limited reported an increase in revenue and net profit for the year ended 31 December 2024, despite challenging macroeconomic conditions. The company’s strategic acquisition of Thailand’s largest dental laboratory, Hexa Ceram, and its focus on digital transformation have strengthened its market position, allowing it to outperform competitors. With production facilities in the US and Southeast Asia, the company is well-positioned to mitigate tariff-related risks and capitalize on market opportunities.
Modern Dental Group Limited has announced a final ordinary cash dividend of HKD 0.092 per share for the financial year ending December 31, 2024. The dividend will be paid on June 30, 2025, following shareholder approval on May 29, 2025. This announcement reflects the company’s financial performance and commitment to returning value to its shareholders.
Modern Dental Group Limited announced the re-designation of Mr. Chan Kwun Fung from an executive to a non-executive director, effective April 1, 2025. This transition is part of a leadership change aimed at fostering a new generation of leadership, with Mr. Chan continuing to serve as a mentor and advisor to the board, ensuring continuity in strategic planning and policy development.
Modern Dental Group Limited has announced an updated list of its board of directors, effective from April 1, 2025. This restructuring includes key executive roles and the composition of three board committees: Audit, Nomination, and Remuneration. The changes are likely to impact the company’s governance and strategic direction, potentially influencing its market position and stakeholder relations.